Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine plus bupivacaine versus bupivacaine alone for ultrasound-guided thoracolumbar interfascial plane block in spine surgery
PACTR201911745756018Phase 0Unknown
- Sponsor
- Mohamed zakarea wfa
- Start
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, open-label trial of dexmedetomidine and bupivacaine in postoperative pain, sponsored by Mohamed zakarea wfa. Primary endpoints: Postoperative pain intensity and Rescue analgesia trigger. Status: unknown.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR201911745756018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201911745756018.